Clinical Trial

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2024 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
It is a randomized, single-center, controlled trial to evaluate the effectiveness of oral immunotherapy with low-dose sesame protein compared with standard treatment (elimination diet) in patients with sesame allergy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-14; most recent amendment 2024-05-16.
Trial Details
NCT Number NCT06261554
Lead Sponsor Medical University of Warsaw
Conditions Food Allergy
Enrollment 39 participants
Start Date 2024-03-14
Primary Completion 2026-03-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2024-05-20